Frauke May

1.4k total citations
17 papers, 1.1k citations indexed

About

Frauke May is a scholar working on Hematology, Genetics and Immunology and Allergy. According to data from OpenAlex, Frauke May has authored 17 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hematology, 7 papers in Genetics and 4 papers in Immunology and Allergy. Recurrent topics in Frauke May's work include Coagulation, Bradykinin, Polyphosphates, and Angioedema (7 papers), Platelet Disorders and Treatments (7 papers) and Blood Coagulation and Thrombosis Mechanisms (7 papers). Frauke May is often cited by papers focused on Coagulation, Bradykinin, Polyphosphates, and Angioedema (7 papers), Platelet Disorders and Treatments (7 papers) and Blood Coagulation and Thrombosis Mechanisms (7 papers). Frauke May collaborates with scholars based in Germany, Australia and United States. Frauke May's co-authors include Bernhard Nieswandt, Irina Pleines, Ina Hagedorn, Margitta Elvers, Timo Vögtle, Markus Bender, Cord Brakebusch, Johannes A. Eble, Johan W. M. Heemskerk and Shuchi Gupta and has published in prestigious journals such as Nature, Blood and PLoS ONE.

In The Last Decade

Frauke May

17 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Frauke May Germany	14	588	239	237	218	197	17	1.1k
Ina Hagedorn Germany	14	517 0.9×	383 1.6×	346 1.5×	139 0.6×	166 0.8×	16	1.4k
Nicolas Prévost United States	14	552 0.9×	440 1.8×	176 0.7×	159 0.7×	162 0.8×	21	1.2k
Masamichi Shiraga Japan	23	877 1.5×	401 1.7×	197 0.8×	103 0.5×	254 1.3×	44	1.6k
Crystal L. Piffath United States	6	615 1.0×	161 0.7×	130 0.5×	69 0.3×	63 0.3×	8	897
Gijsbert van Willigen Netherlands	22	526 0.9×	408 1.7×	117 0.5×	58 0.3×	102 0.5×	43	1.2k
Nassia Methia France	9	1.5k 2.5×	302 1.3×	270 1.1×	91 0.4×	380 1.9×	14	1.9k
Mariska G. Rondaij Netherlands	12	273 0.5×	477 2.0×	180 0.8×	101 0.5×	63 0.3×	17	974
Naoki Asazuma Japan	24	1.1k 1.9×	674 2.8×	283 1.2×	75 0.3×	126 0.6×	39	1.9k
Brenda Finney United Kingdom	13	236 0.4×	182 0.8×	124 0.5×	182 0.8×	50 0.3×	18	645
Marion T.J. van den Bosch United Kingdom	11	300 0.5×	249 1.0×	84 0.4×	66 0.3×	57 0.3×	15	666

Countries citing papers authored by Frauke May

Since Specialization

Citations

This map shows the geographic impact of Frauke May's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frauke May with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frauke May more than expected).

Fields of papers citing papers by Frauke May

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frauke May. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frauke May. The network helps show where Frauke May may publish in the future.

Co-authorship network of co-authors of Frauke May

This figure shows the co-authorship network connecting the top 25 collaborators of Frauke May. A scholar is included among the top collaborators of Frauke May based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frauke May. Frauke May is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Stegner, David, Sarah Beck, Katherina Hemmen, et al.. (2022). Foudroyant cerebral venous (sinus) thrombosis triggered through CLEC-2 and GPIIb/IIIa dependent platelet activation. Nature Cardiovascular Research. 1(2). 132–141. 15 indexed citations

Beck, Sarah, David Stegner, Stefan Loroch, et al.. (2021). Generation of a humanized FXII knock‐in mouse—A powerful model system to test novel anti‐thrombotic agents. Journal of Thrombosis and Haemostasis. 19(11). 2835–2840. 2 indexed citations

Pawaskar, Dipti, Xi Chen, Frauke May, et al.. (2021). Pharmacokinetic/pharmacodynamic modeling for dose selection for the first‐in‐human trial of the activated Factor XII inhibitor garadacimab (CSL312). Clinical and Translational Science. 15(3). 709–720. 16 indexed citations

Doerr, Baerbel, Frauke May, Deya Cherpokova, et al.. (2020). Tissue distribution of rIX‐FP after intravenous application to rodents. Journal of Thrombosis and Haemostasis. 18(12). 3194–3202. 4 indexed citations

May, Frauke, Thomas Weimer, Ingo Pragst, et al.. (2016). The Coagulation Factor XIIa Inhibitor rHA-Infestin-4 Improves Outcome after Cerebral Ischemia/Reperfusion Injury in Rats. PLoS ONE. 11(1). e0146783–e0146783. 31 indexed citations

May, Frauke, Ina Thielmann, Ingo Pragst, et al.. (2016). FXIIa inhibitor rHA‐Infestin‐4: Safe thromboprotection in experimental venous, arterial and foreign surface‐induced thrombosis. British Journal of Haematology. 173(5). 769–778. 37 indexed citations

Mattheij, Nadine J.A., Frauke Swieringa, Tom G. Mastenbroek, et al.. (2015). Coated platelets function in platelet-dependent fibrin formation via integrin α _IIb β ₃ and transglutaminase factor XIII. Haematologica. 101(4). 427–436. 56 indexed citations

Nolte, Marc W., Frauke May, Jenny Björkqvist, et al.. (2014). C1-esterase inhibitor treatment: preclinical safety aspects on the potential prothrombotic risk. Thrombosis and Haemostasis. 112(11). 960–971. 17 indexed citations

Kuijpers, Marijke J. E., Paola E. J. van der Meijden, Marion A.H. Feijge, et al.. (2014). Factor XII Regulates the Pathological Process of Thrombus Formation on Ruptured Plaques. Arteriosclerosis Thrombosis and Vascular Biology. 34(8). 1674–1680. 103 indexed citations

10.

Herzog, Brett H., Jianxin Fu, Stephen J. Wilson, et al.. (2013). Podoplanin maintains high endothelial venule integrity by interacting with platelet CLEC-2. Nature. 502(7469). 105–109. 250 indexed citations

11.

Bender, Markus, Frauke May, Viola Lorenz, et al.. (2013). Combined In Vivo Depletion of Glycoprotein VI and C-Type Lectin-Like Receptor 2 Severely Compromises Hemostasis and Abrogates Arterial Thrombosis in Mice. Arteriosclerosis Thrombosis and Vascular Biology. 33(5). 926–934. 92 indexed citations

12.

Ramanathan, Gajalakshmi, Shuchi Gupta, Ina Thielmann, et al.. (2011). Defective diacylglycerol‐induced Ca2+entry but normal agonist‐induced activation responses in TRPC6‐deficient mouse platelets. Journal of Thrombosis and Haemostasis. 10(3). 419–429. 43 indexed citations

13.

Pleines, Irina, Ina Hagedorn, Shuchi Gupta, et al.. (2011). Megakaryocyte-specific RhoA deficiency causes macrothrombocytopenia and defective platelet activation in hemostasis and thrombosis. Blood. 119(4). 1054–1063. 131 indexed citations

14.

Elvers, Margitta, Irina Pleines, Frauke May, et al.. (2010). Platelet hyperreactivity and a prothrombotic phenotype in mice with a gain‐of‐function mutation in phospholipase Cγ2. Journal of Thrombosis and Haemostasis. 8(6). 1353–1363. 24 indexed citations

15.

May, Frauke, Ina Hagedorn, Irina Pleines, et al.. (2009). CLEC-2 is an essential platelet-activating receptor in hemostasis and thrombosis. Blood. 114(16). 3464–3472. 163 indexed citations

16.

Pleines, Irina, Margitta Elvers, Miroslava Požgajová, et al.. (2008). Rac1 is essential for phospholipase C-γ2 activation in platelets. Pflügers Archiv - European Journal of Physiology. 457(5). 1173–1185. 93 indexed citations

17.

Westley, B R & Frauke May. (1995). In vitro development of tamoxifen resistance. Endocrine Related Cancer. 2(1). 37–44. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact